# Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain

> **NCT01290367** · PHASE2 · COMPLETED · sponsor: **Mesoblast, Ltd.** · enrollment: 100 (actual)

## Conditions studied

- Degenerative Disc Disease

## Interventions

- **BIOLOGICAL:** Single Dose MPCs Injection
- **PROCEDURE:** Single injection of saline solution
- **PROCEDURE:** Single injection of hyaluronic acid
- **BIOLOGICAL:** Single Dose MPCs Injection

## Key facts

- **NCT ID:** NCT01290367
- **Lead sponsor:** Mesoblast, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2013-07
- **Final completion:** 2015-07
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01290367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01290367, "Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01290367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*